Trial intelligence / Profile preview

Efficacy of Brinzolamide Added to Travoprost/Timolol in Glaucoma

NCT00382226Phase 4Completed

Sponsor
Alcon Inc.
Start
Sep 2006
Primary completion
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Glaucoma and ocular hypertension comparing Azopt + TTFC with Placebo + TTFC (2 arms). Primary endpoint: Intraocular Pressure at 12 weeks. Started Sep 2006; status: completed.

02

Drugs

brinzolamide
03

Conditions

Glaucomaocular hypertension

Beyond the preview

Go deeper on NCT00382226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00382226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call